Active RB elicits late G1/S inhibition

Steven P. Angus, Anne F. Fribourg, Michael P. Markey, Sarah L. Williams, Henning Horn, James DeGregori, Timothy F. Kowalik, Kenji Fukasawa, Erik S. Knudsen

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The retinoblastoma tumor suppressor protein (RB) is activated/dephosphorylated to mediate cell cycle inhibition in response to antimitogenic signals. To elucidate the mode of RB action at this critical transition, we utilized cell lines that can be induced to express a constitutively active allele of RB (PSM-RB). As expected, induction of PSM-RB, but not wild-type protein (WT), inhibited progression into S phase. It has been well documented that active RB inhibits E2F reporter activity, and this observation was confirmed upon induction of PSM-RB. Additionally, active RB inhibited E2F-2-mediated stimulation of cyclin E. By contrast, PSM-RB did not affect the mRNA or protein levels of endogenous cyclin E when mediating cell cycle inhibition. Similarly, there was no observable effect on cyclin E protein levels when p16ink4a was utilized to activate endogenous RB. CDK2/cyclin E complex formation was not disrupted and cyclin E-associated kinase activity was retained in the presence of PSM-RB. Additionally, centrosome duplication, a CDK2/cyclin E-dependent event, was not altered in the presence of active RB. Together, these data indicate that active RB does not block the G1/S transition through inhibition of cyclin E expression or activity. In contrast, PSM-RB leads to a dramatic reduction in cyclin A protein levels by coordinate transcriptional repression and degradation. This attenuation of cyclin A protein correlates with cell cycle inhibition. These studies indicate that RB inhibits cell cycle progression by targeting CDK2/cyclin A-dependent events at the G1/S transition to inhibit cell cycle progression.

Original languageEnglish
Pages (from-to)201-213
Number of pages13
JournalExperimental Cell Research
Volume276
Issue number2
DOIs
Publication statusPublished - 2002
Externally publishedYes

Fingerprint

Cyclin E
Cell Cycle
Cyclin A
Proteins
Tumor Suppressor Proteins
Retinoblastoma Protein
Centrosome
S Phase
Phosphotransferases
Alleles
Cell Line
Messenger RNA

Keywords

  • CDK
  • Cell cycle
  • Centrosome
  • Cyclin
  • E2F
  • Tumor suppressor

ASJC Scopus subject areas

  • Cell Biology

Cite this

Angus, S. P., Fribourg, A. F., Markey, M. P., Williams, S. L., Horn, H., DeGregori, J., ... Knudsen, E. S. (2002). Active RB elicits late G1/S inhibition. Experimental Cell Research, 276(2), 201-213. https://doi.org/10.1006/excr.2002.5510

Active RB elicits late G1/S inhibition. / Angus, Steven P.; Fribourg, Anne F.; Markey, Michael P.; Williams, Sarah L.; Horn, Henning; DeGregori, James; Kowalik, Timothy F.; Fukasawa, Kenji; Knudsen, Erik S.

In: Experimental Cell Research, Vol. 276, No. 2, 2002, p. 201-213.

Research output: Contribution to journalArticle

Angus, SP, Fribourg, AF, Markey, MP, Williams, SL, Horn, H, DeGregori, J, Kowalik, TF, Fukasawa, K & Knudsen, ES 2002, 'Active RB elicits late G1/S inhibition', Experimental Cell Research, vol. 276, no. 2, pp. 201-213. https://doi.org/10.1006/excr.2002.5510
Angus SP, Fribourg AF, Markey MP, Williams SL, Horn H, DeGregori J et al. Active RB elicits late G1/S inhibition. Experimental Cell Research. 2002;276(2):201-213. https://doi.org/10.1006/excr.2002.5510
Angus, Steven P. ; Fribourg, Anne F. ; Markey, Michael P. ; Williams, Sarah L. ; Horn, Henning ; DeGregori, James ; Kowalik, Timothy F. ; Fukasawa, Kenji ; Knudsen, Erik S. / Active RB elicits late G1/S inhibition. In: Experimental Cell Research. 2002 ; Vol. 276, No. 2. pp. 201-213.
@article{fee7c2ac3c764ec18e2d6572d8b7d065,
title = "Active RB elicits late G1/S inhibition",
abstract = "The retinoblastoma tumor suppressor protein (RB) is activated/dephosphorylated to mediate cell cycle inhibition in response to antimitogenic signals. To elucidate the mode of RB action at this critical transition, we utilized cell lines that can be induced to express a constitutively active allele of RB (PSM-RB). As expected, induction of PSM-RB, but not wild-type protein (WT), inhibited progression into S phase. It has been well documented that active RB inhibits E2F reporter activity, and this observation was confirmed upon induction of PSM-RB. Additionally, active RB inhibited E2F-2-mediated stimulation of cyclin E. By contrast, PSM-RB did not affect the mRNA or protein levels of endogenous cyclin E when mediating cell cycle inhibition. Similarly, there was no observable effect on cyclin E protein levels when p16ink4a was utilized to activate endogenous RB. CDK2/cyclin E complex formation was not disrupted and cyclin E-associated kinase activity was retained in the presence of PSM-RB. Additionally, centrosome duplication, a CDK2/cyclin E-dependent event, was not altered in the presence of active RB. Together, these data indicate that active RB does not block the G1/S transition through inhibition of cyclin E expression or activity. In contrast, PSM-RB leads to a dramatic reduction in cyclin A protein levels by coordinate transcriptional repression and degradation. This attenuation of cyclin A protein correlates with cell cycle inhibition. These studies indicate that RB inhibits cell cycle progression by targeting CDK2/cyclin A-dependent events at the G1/S transition to inhibit cell cycle progression.",
keywords = "CDK, Cell cycle, Centrosome, Cyclin, E2F, Tumor suppressor",
author = "Angus, {Steven P.} and Fribourg, {Anne F.} and Markey, {Michael P.} and Williams, {Sarah L.} and Henning Horn and James DeGregori and Kowalik, {Timothy F.} and Kenji Fukasawa and Knudsen, {Erik S.}",
year = "2002",
doi = "10.1006/excr.2002.5510",
language = "English",
volume = "276",
pages = "201--213",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Active RB elicits late G1/S inhibition

AU - Angus, Steven P.

AU - Fribourg, Anne F.

AU - Markey, Michael P.

AU - Williams, Sarah L.

AU - Horn, Henning

AU - DeGregori, James

AU - Kowalik, Timothy F.

AU - Fukasawa, Kenji

AU - Knudsen, Erik S.

PY - 2002

Y1 - 2002

N2 - The retinoblastoma tumor suppressor protein (RB) is activated/dephosphorylated to mediate cell cycle inhibition in response to antimitogenic signals. To elucidate the mode of RB action at this critical transition, we utilized cell lines that can be induced to express a constitutively active allele of RB (PSM-RB). As expected, induction of PSM-RB, but not wild-type protein (WT), inhibited progression into S phase. It has been well documented that active RB inhibits E2F reporter activity, and this observation was confirmed upon induction of PSM-RB. Additionally, active RB inhibited E2F-2-mediated stimulation of cyclin E. By contrast, PSM-RB did not affect the mRNA or protein levels of endogenous cyclin E when mediating cell cycle inhibition. Similarly, there was no observable effect on cyclin E protein levels when p16ink4a was utilized to activate endogenous RB. CDK2/cyclin E complex formation was not disrupted and cyclin E-associated kinase activity was retained in the presence of PSM-RB. Additionally, centrosome duplication, a CDK2/cyclin E-dependent event, was not altered in the presence of active RB. Together, these data indicate that active RB does not block the G1/S transition through inhibition of cyclin E expression or activity. In contrast, PSM-RB leads to a dramatic reduction in cyclin A protein levels by coordinate transcriptional repression and degradation. This attenuation of cyclin A protein correlates with cell cycle inhibition. These studies indicate that RB inhibits cell cycle progression by targeting CDK2/cyclin A-dependent events at the G1/S transition to inhibit cell cycle progression.

AB - The retinoblastoma tumor suppressor protein (RB) is activated/dephosphorylated to mediate cell cycle inhibition in response to antimitogenic signals. To elucidate the mode of RB action at this critical transition, we utilized cell lines that can be induced to express a constitutively active allele of RB (PSM-RB). As expected, induction of PSM-RB, but not wild-type protein (WT), inhibited progression into S phase. It has been well documented that active RB inhibits E2F reporter activity, and this observation was confirmed upon induction of PSM-RB. Additionally, active RB inhibited E2F-2-mediated stimulation of cyclin E. By contrast, PSM-RB did not affect the mRNA or protein levels of endogenous cyclin E when mediating cell cycle inhibition. Similarly, there was no observable effect on cyclin E protein levels when p16ink4a was utilized to activate endogenous RB. CDK2/cyclin E complex formation was not disrupted and cyclin E-associated kinase activity was retained in the presence of PSM-RB. Additionally, centrosome duplication, a CDK2/cyclin E-dependent event, was not altered in the presence of active RB. Together, these data indicate that active RB does not block the G1/S transition through inhibition of cyclin E expression or activity. In contrast, PSM-RB leads to a dramatic reduction in cyclin A protein levels by coordinate transcriptional repression and degradation. This attenuation of cyclin A protein correlates with cell cycle inhibition. These studies indicate that RB inhibits cell cycle progression by targeting CDK2/cyclin A-dependent events at the G1/S transition to inhibit cell cycle progression.

KW - CDK

KW - Cell cycle

KW - Centrosome

KW - Cyclin

KW - E2F

KW - Tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=0036353035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036353035&partnerID=8YFLogxK

U2 - 10.1006/excr.2002.5510

DO - 10.1006/excr.2002.5510

M3 - Article

VL - 276

SP - 201

EP - 213

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 2

ER -